$MRK Company News Biotechs continue to pay off 10:27 a.m.

New Post Public Reply Private Reply Replies (0) Message Board

Dec 20, 2013 at 11:38 AM

$MRK Company News

Biotechs continue to pay off 10:27 a.m. Today - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan

Merck Launches Weight-Management-Interventions Business 10:06 a.m. Today - WSJ.com
What To Buy: Merck & Co Inc's Buy Recommendation Reiterated 9:00 a.m. Today - TheStreet.com
'Dogs of the Dow' Strategy Should Be Muzzled 6:42 p.m. Dec. 19, 2013 - Barrons.com
Bristol-Myers Doubles Down on Cancer Focus 3:14 p.m. Dec. 19, 2013 - Barrons.com
The Battle Against Alzheimer's: Can An Investment In The Industry Prove Lucrative? 2:27 p.m. Dec. 19, 2013 - Seeking Alpha
French authority alleges anti-competitive practices in opioid addiction market 2:21 p.m. Dec. 19, 2013 - Seeking Alpha
Merck-Glaxo Partner for Oncology Treatment - Analyst Blog 1:20 p.m. Dec. 19, 2013 - Zacks.com
Stock Market News for December 19, 2013 - Market News 10:06 a.m. Dec. 19, 2013 - Zacks.com
Jim Cramer's Top Stock Picks: MRK AMAT CIEN XLNX GIS 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Sanofi Pipeline Doesn't Support Price 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Anacor Pharmaceuticals Is Not for Everyone 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Cramer's Mad Money - Thank You, Ben Bernanke (12/18/13) 5:46 a.m. Dec. 19, 2013 - Seeking Alpha
11 Stocks With Buybacks That Top $166 BILLION 12:16 a.m. Dec. 19, 2013 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: The Fed Tapers? So What? 8:26 p.m. Dec. 18, 2013 - TheStreet.com
Merck Vs. Bristol In PD-1 Cancer Drug Race 6:48 p.m. Dec. 18, 2013 - Seeking Alpha
Top Five Guru-Held Health Care Stocks 4:42 p.m. Dec. 18, 2013 - GuruFocus.com
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - CNW Group
Merck, Glaxo to Partner on Renal Cell Cancer Treatment 8:06 a.m. Dec. 18, 2013 - WSJ.com
Merck, Glaxo to test combo treatment in renal cell carcinoma 7:56 a.m. Dec. 18, 2013 - Seeking Alpha
5 Pharma Stocks to Buy for Big Dividends 3:40 a.m. Dec. 18, 2013 - InvestorPlace.com

Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Today - ACCESSWIRE
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S. 9:00 a.m. Today - BusinessWire
Critical Alerts For eBay, Merck, Michael Kors, Delta Air Lines, and Tiffany Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - PR Newswire
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma 7:30 a.m. Dec. 18, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO(TM) (fluralaner) 4:00 a.m. Dec. 17, 2013 - BusinessWire
When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Merck Statement on FDA Advisory Committee for GRASTEK(R) (Timothy Grass Pollen Allergen Extract), Merck's Investigational Sublingual Allergy Immunotherapy Tablet 7:17 p.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee meeting unanimously recommends approval of GRASTEK (GRAZAX(R)) 4:13 p.m. Dec. 12, 2013 - GlobeNewswire
Heska Announces Extension of Tri-Heart(TM) Plus Heartworm Preventive Agreement with Merck Animal Health 9:00 a.m. Dec. 12, 2013 - PR Newswire
Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
OncoSec Medical Announces Hire of Chief Medical Officer 6:05 a.m. Dec. 12, 2013 - BusinessWire
TechConnect World and National Innovation Summit Announce Lead Corporate Partners for 2014 10:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet 8:22 a.m. Dec. 10, 2013 - GlobeNewswire
Merck Advances Development Program for Investigational Alzheimer's Disease Therapy, MK-8931 7:00 a.m. Dec. 10, 2013 - BusinessWire
Exostar-Powered Identity & Access Management Platform Named North America Health Care Project of the Year 9:09 a.m. Dec. 5, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DayOne's Bold Energy Moves With Sembcorp for Asia Growth

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Young Leaders Drive Be Strong’s Mental Health Movement

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Spotting Alzheimer's: Holiday Visits Might Reveal More

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

Yale's $10M Inflammation Initiative: Future Health Impact

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

CloudKeeper Simplifies AI Cost Tracking with FinOps Launch

AI Cost Management: A Complex Endeavor Tracking the myriad costs of AI operations can be downright infuriating. Every company dipping its toes in these waters quickly finds itself tangled in a web of fees spanning different models, applications, and cloud services. This tangled mess is about to get some much-needed untangling, thanks to CloudKeeper's latest move. They're...

Quanta Services Reports Record Q3 2026 Earnings

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Wabi's $1.25B Valuation: A New Era for AI?

By Logan Wright Updated Oct 29, 2026 Category News Views 155

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

ACTEC Welcomes 55 New Fellows: A Closer Look

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Static Media Acquires CarScoops to Boost Auto Reach

Static Media's Latest Move in the Automotive Arena The digital media landscape keeps morphing, and Static Media just decided to crank up the gears a notch by snapping up CarScoops.com. For those with an eye on the automotive field, it's the kind of play that could shift the tides. Static Media, already a heavyweight with brands like Jalopnik and SlashGear under its belt,...